MW
MRNA icon

Milestone Wealth’s Moderna MRNA Stock Holding History

Milestone Wealth’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$209K Hold
1,766
– – 0.23% 46
2022
Q2 		$252K Buy
1,766
+1,500
+564% +$214K 0.27% 45
2022
Q1 		$68K Hold
266
– – 0.06% 107
2021
Q4 		$68K Buy
+266
New +$77.8K 0.05% 107

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Milestone Wealth's MRNA Position: Q3 2022 in Review

Milestone Wealth held its Moderna (MRNA) position steady in Q3 2022 at 1,766 shares worth $209K. The position accounts for 0.23% of the portfolio, ranked #46.

Milestone Wealth first reported a position in MRNA in Q4 2021 and has held it in 4 quarters since. The position peaked at $252K in Q2 2022. 914 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • Milestone Wealth held 1,766 shares of Moderna worth $209K as of Q3 2022.
  • Milestone Wealth left its Moderna share count unchanged in Q3 2022.
  • Moderna made up 0.23% of Milestone Wealth's portfolio in Q3 2022, its #46 holding.
  • Milestone Wealth first reported a position in Moderna in Q4 2021 and has held it in 4 quarters since.
  • Milestone Wealth's Moderna position peaked at $252K in Q2 2022.
  • 914 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Milestone Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.